AXN - Aoxing Pharmaceutical Company, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.1218
-0.0076 (-5.8733%)
At close: 3:53PM EDT
Stock chart is not supported by your current browser
Previous Close0.1294
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume283,628
Market Cap9.28M
Beta3.03
PE Ratio (TTM)-6.41
EPS (TTM)-0.02
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
Trade prices are not sourced from all markets
  • How Does Investing In Aoxing Pharmaceutical Company Inc (AXN) Impact Your Portfolio?
    Simply Wall St.14 days ago

    How Does Investing In Aoxing Pharmaceutical Company Inc (AXN) Impact Your Portfolio?

    If you are a shareholder in Aoxing Pharmaceutical Company Inc’s (AMEX:AXN), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile ofRead More...

  • ACCESSWIRE23 days ago

    Aoxing Pharmaceutical Announces Delisting and Deregistration of Common Stock

    FOSTER CITY, CA / ACCESSWIRE / September 25, 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE American: AXN) today announced that its board of directors has made a determination to remove the Aoxing Pharma ...

  • Should You Be Holding Aoxing Pharmaceutical Company Inc (AXN) Right Now?
    Simply Wall St.29 days ago

    Should You Be Holding Aoxing Pharmaceutical Company Inc (AXN) Right Now?

    If you are looking to invest in Aoxing Pharmaceutical Company Inc’s (AMEX:AXN), or currently own the stock, then you need to understand its beta in order to understand how itRead More...

  • Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017
    Capital Cube5 months ago

    Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Aoxing Pharmaceutical Co., Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Aoxing Pharmaceutical Co., Inc. – Pfizer Inc., Catalyst Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Omeros Corporation, Amicus Therapeutics, Inc., ... Read more (Read more...)

  • Accesswire5 months ago

    Aoxing Pharmaceutical Reports Q3 Fiscal 2017 Financial Results

    FOSTER CITY, CA / ACCESSWIRE / May 15 , 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that for the third quarter of fiscal year 2017, ended March 31, 2017, the Company reported ...

  • Associated Press5 months ago

    Aoxing posts 3Q profit

    The Shijiazhuang City, China-based company said it had net income of less than 1 cent on a per-share basis. The specialty pharmaceutical company posted revenue of $5.7 million in the period. The company's ...

  • Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017
    Capital Cube7 months ago

    Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017

    Categories: Yahoo Finance Get free summary analysis Aoxing Pharmaceutical Co., Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Aoxing Pharmaceutical Co., Inc. – Pfizer Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Amicus Therapeutics, Inc. and Array BioPharma Inc. (PFE-US, IPXL-US, JNJ-US, MYL-US, FOLD-US ... Read more (Read more...)

  • Accesswire8 months ago

    Aoxing Pharmaceutical Reports Q2 Fiscal 2017 Financial Results

    FOSTER CITY, CA / ACCESSWIRE / February 14 , 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that for the second quarter of fiscal year 2017, ended December 31, 2016, the Company ...

  • Accesswire11 months ago

    Aoxing Pharmaceutical Reports Q1 Fiscal 2017 Financial Results

    FOSTER CITY, CA / ACCESSWIRE / November 14 , 201 6 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that for the first quarter of fiscal year 2017, ended September 30, 2016, the Company ...